Pharma Journalist - Page 35 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Novartis’ Ianalumab Earns FDA Breakthrough Status in Sjögren’s Disease

AstraZeneca Acquires Modella AI to Advance Oncology Innovation

Agenus, Zydus Finalize Strategic Immunotherapy Collaboration

EMA, FDA Set Global Principles for AI in Medicines

InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy

Illumina Launches Billion Cell Atlas to Power AI Drug Discovery

Novartis Licenses SciNeuro’s Brain-Targeting Alzheimer’s Antibody Program

NVIDIA and Lilly Launch $1 Billion AI Drug Discovery Lab

FDA Issues Complete Response Letter for Atara’s EBVALLO Therapy

AbbVie Reaches Deal With Trump Administration on Drug Pricing